The Translational Bridge Award (TBA) ($450,000 over 2 years) provides funding to bridge the gap between post-discovery and pre-commercial development and to accelerate the pace at which promising LRA-funded foundational research discoveries are translated into clinical evaluation and transitioned to a viable product that impacts patients directly.
2026 Funded Grants
-
Phosphatase-activating antibody for cutaneous lupus therapy
Nunzio Bottini, MD, PhD
Cedars-Sinai Medical Center
-
Targeting pathogenic endothelial dysfunction in systemic lupus erythematosus: translation to clinical trials
Jim Oates, MD
Medical University of South Carolina
2024 Funded Grants
-
Transcutaneous Vagus Nerve Stimulation in SLE (TvSSLE)
Cynthia Aranow, M.D.
The Feinstein Institutes for Medical Research
-
High-Dimensional Imaging to Define Prognostic States in H&E Stained LN Biopsies
Marcus Clark, M.D.
The University of Chicago
-
Small Molecule Targeting ITGAM in Lupus
Timothy Niewold, M.D.
The Hospital for Special Surgery
-
Serum Analytes Differentiate Between SLE Patients With and Without CI
Zahi Touma, M.D., Ph.D.
University Health Network